Aflac Incorporated's SEC filings document a supplemental health and life insurer with reportable operations in Japan and the United States. Form 8-K reports furnish quarterly and annual results, supplemental earnings materials, investor presentations and Regulation FD disclosures tied to segment performance, premiums, investment income, dividends and share repurchases.
Proxy and annual-meeting filings cover board elections, executive compensation votes, auditor ratification, shareholder proposals and common-stock voting matters. Other material-event filings describe financing arrangements, including pre-capitalized trust securities and contingent senior-note funding, as well as cybersecurity incident disclosures, operational continuity, customer information risks, governance controls and public-company reporting obligations.
Aflac Incorporated filed an 8-K announcing its 2025 third quarter results. The company furnished a press release and supplemental earnings materials as Exhibits 99.1 and 99.2 dated November 4, 2025.
Under Regulation FD, Aflac also posted a video presentation by Senior Executive Vice President and CFO Max Brodén on investors.aflac.com, with the transcript and slides furnished as Exhibits 99.3 and 99.4.
Max K. Broden, Sr. EVP and CFO of Aflac Incorporated (AFL), filed a Form 4 reporting insider transactions dated 09/23/2025. The filing lists a transaction coded F disposing of 33 shares at a price of $108.23. The form shows 339 shares beneficially owned following the reported transaction(s). The filing also includes an entry showing Common Stock 130,353 D (disposition) on the form. The Form 4 was signed for Max K. Broden by Cathryn S. Smitherman on 09/25/2025.
Frederic Simard, listed as EVP, COO & CFO, Aflac U.S., reported a sale of 493 shares of AFL common stock on 09/15/2025 at a price of $108.41 per share. After the sale he beneficially owns 3,086 shares directly and holds 589 shares indirectly through a 401(k) plan. The Form 4 was signed on 09/17/2025.
Aflac Incorporated entered into two contingent funding arrangements through Wynnton Funding Trusts that issued $1,000,000,000 of 2035 P-Caps and $1,000,000,000 of 2055 P-Caps to institutional investors. In return, Aflac pays a 0.9875% facility fee per annum on an unexercised right to issue up to $1,000,000,000 of 5.251% Senior Notes due 2035 and a 1.1218% facility fee per annum on an unexercised right to issue up to $1,000,000,000 of 5.991% Senior Notes due 2055. These Issuance Rights can be exercised voluntarily or automatically upon events such as missed facility fee payments, certain bankruptcy events, or if Aflac’s consolidated net worth (excluding accumulated other comprehensive income and certain non-controlling interests) falls below $10 billion, giving the company pre-arranged access to long-dated senior funding.
Joseph L. Moskowitz, a director of Aflac Inc. (AFL), reported a change in beneficial ownership on 08/18/2025. The filing shows 500 shares disposed (D) of Aflac common stock under transaction code G at a recorded price of $0, leaving 24,605 shares beneficially owned directly after the transaction. The Form 4 was signed on 08/20/2025.
Bradley E. Dyslin, Executive Vice President of Aflac Incorporated, received a grant of 9,658 shares of Aflac common stock under the companys Long-Term Incentive Plan. The award was recorded as an acquisition and is listed at a price of $0, indicating a grant rather than a market purchase. Following this transaction, Mr. Dyslins reported beneficial ownership of Aflac common stock is 29,162 shares, held directly.
The Form 4 discloses the transaction class as common stock and cites the Long-Term Incentive Plan (as amended and restated February 14, 2017) as the grant source. The filing identifies Mr. Dyslin as an officer (Executive Vice President) of the issuer.
Joseph L. Moskowitz, identified as a Director of Aflac Inc., reported the sale of 1,000 shares of Aflac common stock on 08/08/2025 at a price of $102.57 per share. After the reported transaction the filing shows he beneficially owned 25,105 shares. The Form 4 indicates it was filed by one reporting person and bears a signature date of 08/12/2025.
The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2024. No derivative transactions are reported in the document, and the form includes the reporting person's address and role. The disclosure is limited to the transactions described and the plan referenced.
Aflac Inc. (AFL) Form 144 filing: insider Joseph L. Moskowitz has notified intent to sell 1,000 common shares through Fidelity Brokerage Services on or about 08 Aug 2025. At the recent market price of $102.57, the proposed sale is valued at ≈$103 k. The shares originated from restricted-stock vesting on 01 May 2024 and represent only 0.0002 % of Aflac’s ≈534.8 m shares outstanding.
The seller previously disposed of an identical 1,000-share block on 08 May 2025 for proceeds of $106.8 k. No material adverse information was acknowledged, and the filer affirms compliance with Rule 144 and, if applicable, Rule 10b5-1.
Materiality: Transaction size is immaterial relative to market cap; therefore, limited impact on valuation or liquidity is expected.